The pharmacokinetics and pharmacodynamics of OPG following single dose administration in cynomolgus monkeys.

被引：0
|
作者：
Martin, SW [1 ]
Sommers, JS [1 ]
Watson, AM [1 ]
Young, JD [1 ]
Dunstan, CR [1 ]
机构：
[1] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 1999年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SA361
引用
收藏
页码：S399 / S399
页数：1
相关论文
共 50 条
  • [1] Comparison of the pharmacodynamics of an osteoprotegerin (OPG) analogue and ibandronic acid following single dose intravenous administration to cynomolgus monkeys.
    Martin, SW
    Sommers, JS
    Stouch, BJ
    Young, JD
    Dunstan, CR
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S171 - S171
  • [2] Pharmacokinetics and pharmacodynamics of CI-992 following intravenous and oral administration to cynomolgus monkeys
    Cook, JA
    Burger, PJ
    Michniewicz, BM
    Nordblom, GD
    Hicks, GW
    Kaplan, C
    Ryan, MJ
    [J]. BIOPHARMACEUTICS & DRUG DISPOSITION, 1998, 19 (03) : 185 - 191
  • [3] Ocular pharmacokinetics (PK) or rhuFab V2 following intravitreal (ITV) administration in cynomolgus monkeys.
    Gaudreault, J
    Fei, D
    Suboc, P
    Chan, P
    Nelson, J
    Lappin, P
    Hartmangruber, M
    Rusit, J
    O'Neill, C
    Hsei, V
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S933 - S933
  • [4] Pharmacokinetics, pharmacodynamics, and toxicity of a PD-1-targeted IL-15 in cynomolgus monkeys.
    Ji, Changhua
    Kuang, Bing
    Buetow, Bernard S.
    Vitsky, Allison
    Xu, Yuanming
    Matsumoto, Diane
    Kraynov, Eugenia
    Chaparro-Riggers, Javier
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] Population, pharmacokinetics (PK) of bevacizumab (BV) in cynomolgus monkeys.
    Gaudreault, J
    Siguenza, P
    O'Neill, C
    Torres, E
    Vogel, J
    Hsei, V
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P97 - P97
  • [6] Pharmacokinetics and pharmacodynamics of KS01017 following single dose administration.
    Menon, R.
    Tolbert, D.
    Leu, J.
    Cefali, E.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S118 - S118
  • [7] Bone mineral density is increased following monthly administration of AMG 162 in cynomolgus monkeys.
    Atkinson, JE
    Cranmer, P
    Mohr, S
    Niehaus, M
    Jerome, CP
    Cosenza, ME
    Dunstan, CR
    DePaoli, AM
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S96 - S96
  • [8] Pharmacokinetics of the proteasome inhibitor bortezomib (VELCADE™) in male cynomolgus monkeys.
    Nix, D
    Milton, M
    Pligavko, C
    Nagaraja, N
    Huang, R
    Miwa, G
    [J]. CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6263S - 6263S
  • [9] PHARMACOKINETICS AND PHARMACODYNAMICS OF GS-3583 IN CYNOMOLGUS MONKEYS
    Kuhne, Michelle
    Chu, Hamlet
    Clarke, Christopher
    Carr, Brian
    Baca, Manuel
    Hung, Magdeleine
    Nagel, Mark
    Ambrogelly, Alexandre
    Rajakumaraswamy, Nishanathan
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A888 - A888
  • [10] Pharmacodynamics and pharmacokinetics of cefoperazone and cefamandole in dogs following single dose intravenous and intramuscular administration
    Montesissa, C
    Villa, R
    Anfossi, P
    Zanoni, R
    Carli, S
    [J]. VETERINARY JOURNAL, 2003, 166 (02): : 170 - 176
12345